SEARCH

SEARCH BY CITATION

References

  • 1
    Carruthers JA, Lowe NJ, Menter MA, et al. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol 2002;46:8409.
  • 2
    Carruthers JDA, Carruthers JA. Treatment of glabellar frown lines with C botulinum A exotoxin. J Dermatol Surg Oncol 1992;18:1721.
  • 3
    Goodman G. Botulinum toxin for the correction of hyperkinetic facial lines. Australas J Dermatol 1998;39:15863.
  • 4
    Keen M, Blitzer A, Aviv J, et al. Botulinum toxin A for hyperkinetic facial lines: results of a double-blind, placebo-controlled study. Plast Reconstr Surg 1994;94:949.
  • 5
    Harii K, Kawashima M. A double-blind, randomized, placebo-controlled, two-dose comparative study of botulinum toxin type a for treating glabellar lines in Japanese subjects. Aesthetic Plast Surg 2008;32:72430.
  • 6
    Fagien S, Cox SE, Finn JC, et al. Patient-reported outcomes with botulinum toxin type A treatment of glabellar rhytids: a double-blind, randomized, placebo-controlled study. Dermatol Surg 2007;33 (1 Spec No.):S29.
  • 7
    Carruthers A, Carruthers J. Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids. Dermatol Surg 2005;31:1297303.
  • 8
    Carruthers A, Carruthers J, Said S. Dose-ranging study of botulinum toxin type A in the treatment of glabellar rhytids in females. Dermatol Surg 2005;31:41422; discussion 422.
  • 9
    Carruthers JD, Lowe NJBoNTA Glabellar Lines II Study Group. et al. Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines. Plast Reconstr Surg 2003;112:108998.
  • 10
    Foster J, Barhorst D, Palpay F, et al. The use of botulinum A toxin to ameliorate facial kinetic frown lines. Ophthalmology 1996;103:61822.
  • 11
    Klein A. Cosmetic therapy with botulinum toxin. Dermatol Surg 1996;22:7579.
  • 12
    Letessier S. Treatment of wrinkles with botulinum toxin. J Dermatol 2001;145:28993.
  • 13
    Lowe N, Maxwell A, Harper H, et al. Botulinum A exotoxin for glabellar folds: a double-blind, placebo-controlled study with an electromyographic injection technique. J Am Acad Dermatol 1996;35:56972.
  • 14
    Carruthers A, Kiene K, Carruthers J. Botulinum A exotoxin use in clinical dermatology. J Am Acad Dermatol 1996;34:78897.
  • 15
    Carruthers A, Carruthers J. Cosmetic uses of botulinum A exotoxin. Adv Dermatol 1997;12:32547.
  • 16
    Carruthers A, Carruthers JDA. Botulinum toxin in the treatment of glabellar frown lines and other facial wrinkles. In: JankovicJ, HallettM, editors. Therapy with Botulinum Toxin. New York: Marcel Dekker; 1994. p. 57795.
  • 17
    Koch JR, Troell RJ, Goode RL. Contemporary management of the aging brow and forehead. Laryngoscope 1997;107:7105.
  • 18
    Lowe NJ, Maxwell A, Harper H. Botulinum A exotoxin for glabellar folds: a double-blind, vehicle-controlled study with an electromyographic injection technique. J Am Acad Dermatol 1996;35:56972.
  • 19
    Keen M, Blitzer A, Aviv J, et al. Botulinum toxin A for hyperkinetic facial lines: results of a double-blind, vehicle-controlled study. Plast Reconstr Surg 1994;94:949.
  • 20
    Carruthers A, Carruthers J. Cosmetic uses of botulinum A exotoxin. In: KlenAW, editor. Tissue Augmentation in Clinical Practice. New York: Marcel Dekker; 1998. p. 20736.